Ignite Creation Date:
2025-12-26 @ 12:18 PM
Ignite Modification Date:
2026-02-03 @ 5:36 AM
Study NCT ID:
NCT03218800
Status:
TERMINATED
Last Update Posted:
2022-08-11
First Post:
2017-07-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ertapenem Administered Subcutaneously Versus Intravenously
Sponsor:
Instituto Nacional de Cancer, Brazil
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Urinary Tract Infections | View |